Inicio/Acciones/XOMAP

XOMAP

USD

XOMA Royalty Corporation 8.625% Series A Cumulative Perpetual Preferred Stock

$25.600+0.000 (0.000%)

Precio en Tiempo Real

Healthcare

Biotecnología

Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado

Fundamentos de la Empresa

Estadísticas de Negociación

Métricas de Mercado

Apertura

$25.600

Máximo

$25.600

Mínimo

$25.600

Volumen

0.00M

Fundamentos de la Empresa

Industria

Biotecnología

País

United States

Estadísticas de Negociación

Volumen Promedio

0.00M

Bolsa

NGM

Moneda

USD

Rango de 52 Semanas

Mínimo $24.96Actual $25.600Máximo $26.51

Noticias Relacionadas

27 may 2025 · 12:01

GlobeNewswire

XOMA Royalty Purchases Mezagitamab Royalty and Milestone Rights Held by BioInvent International for up to USD $30 Million

EMERYVILLE, Calif. and LUND, Sweden, May 27, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ:XOMA), the biotech royalty aggregator, and BioInvent International AB ("BioInvent") (Nasdaq Stockholm: BINV), a

XOMA Royalty Purchases Mezagitamab Royalty and Milestone Rights Held by BioInvent International for up to USD $30 Million

7 may 2025 · 11:30

GlobeNewswire

XOMA Royalty to Present at H.C. Wainwright 1st Annual Royalty Company Virtual Conference

EMERYVILLE, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ:XOMA), the biotech royalty aggregator, announced today its Chief Executive Officer, Owen Hughes, and Chief Investment Officer, Brad